Medium Term Effects of Different Dosage of Diuretic, Sodium, and Fluid Administration on Neurohormonal and Clinical Outcome in Patients With Recently Compensated Heart Failure

被引:135
作者
Paterna, Salvatore [2 ]
Parrinello, Gaspare [3 ]
Cannizzaro, Sergio [1 ]
Fasullo, Sergio [1 ]
Torres, Daniele [3 ]
Sarullo, Filippo M. [4 ]
Di Pasquale, Pietro [1 ]
机构
[1] GF Ingrassia Hosp, Div Cardiol Paolo Borsellino, Palermo, Italy
[2] Univ Palermo, Dept Emergency Med, Palermo, Italy
[3] Univ Palermo, Dept Internal Med, Palermo, Italy
[4] Buccheri la Ferla Hosp, Div Cardiol, Palermo, Italy
关键词
HIGH-DOSE FUROSEMIDE; HYPERTONIC SALINE SOLUTION; BRAIN NATRIURETIC PEPTIDE; SOLUTION INFUSION; BOLUS; SALT; EFFICACY;
D O I
10.1016/j.amjcard.2008.08.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies have shown that patients with compensated heart failure (HF) receiving high diuretic doses associated with normal sodium diet and fluid intake restrictions demonstrated significant reductions in readmissions and mortality compared with those who received low-sodium diets, and. over a 6-month observation period, a reduction in neurohormonal activation was also observed. The aim of this study was to evaluate the effects of different sodium diets associated with different diuretic doses and different levels of fluid intake on hospital readmissions and neurohormonal changes after 6-month follow-up in patients with compensated HF. Four hundred ten consecutive patients with compensated HF (New York Heart Association class II to IV) aged 53 to 86 years, with ejection fractions <35% and serum creatinine <2 mg/dl, were randomized into 8 groups: group A (n = 52): 1,000 ml/day of fluid intake, 120 mmol/day, and 250 mg furosemide twice daily; group B (n = 51): 1,000 ml/day of fluid intake, 120 mmol/day, and 125 mg furosemide twice daily; group C (n = 51): 1,000 ml/day fluid intake, 80 mmol/day, and 250 mg furosemide twice daily; group D (n = 51): 1,000 ml/day fluid intake, 80 mmol/day, and 1.25 mg furosemide twice daily; group E (n = 52): 2,000 ml/day fluid intake, 120 mmol/day, and 250 mg furosemide twice daily; group F (n = 50): 2,000 ml/day fluid intake, 120 mmol/day, and 125 mg furosemide-twice daily; group G (n = 52): 2,000 ml/day fluid intake, 80 mmol/day, and 250 mg furosemide twice daily; and group H (n = 51): 2,000 ml/day fluid intake, 80 mmol/day, and 125 mg furosemide twice daily. All patients received the treatments >= 30 days after discharge and for 180 days afterward. Signs of HF, body weight, blood pressure, heart rate, laboratory parameters, electrocardiograms, echocardiograms, brain natriuretic peptide, aldosterone, and plasma renin activity were examined at baseline and 180 days later. Group A showed the best results, with a significant reduction (p <0.001) in readmissions, brain natriuretic peptide, aldosterone, and plasma renin activity compared with the other groups during follow-up (p <0.001). In conclusion, these data suggest that the combination of a normal-sodium diet with high diuretic doses and fluid intake restriction, compared with different combinations of sodium diets with more modest fluid intake restrictions and conventional diuretic doses, leads to reductions in readmissions, neurohormonal activation, and renal dysfunction. (C) 2009 Elsevier Inc. All rights reserved. (Am J Cardiol 2009;103:93-102)
引用
收藏
页码:93 / 102
页数:10
相关论文
共 26 条
[1]   MANAGEMENT OF REFRACTORY CONGESTIVE-HEART-FAILURE [J].
CODY, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (18) :G141-G149
[2]  
Commission of the European Communities, 1993, NUTR EN INT EUR COMM
[3]  
Cowie MR, 1997, EUR HEART J, V18, P208
[4]   Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure [J].
Damgaard, M ;
Norsk, P ;
Gustafsson, F ;
Kanters, JK ;
Christensen, NJ ;
Bie, P ;
Friberg, L ;
Gadsboll, N .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2006, 290 (05) :R1294-R1301
[5]   Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion [J].
Dormans, TPJ ;
vanMeyel, JJM ;
Gerlag, PGG ;
Tan, Y ;
Russel, FGM ;
Smits, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (02) :376-382
[6]   Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure [J].
Gabrielsen, A ;
Bie, P ;
Holstein-Rathlou, NH ;
Christensen, NJ ;
Warberg, J ;
Dige-Petersen, H ;
Frandsen, E ;
Galatius, S ;
Pump, B ;
Sorensen, VB ;
Kastrup, J ;
Norsk, P .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 281 (02) :R459-R467
[7]  
Issa VS, 2007, ARQ BRAS CARDIOL, V89, P251, DOI 10.1590/S0066-782X2007001600007
[8]  
LECLERCQ C, 1991, EUR J CLIN NUTR, V45, P151
[9]   Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects [J].
Licata, G ;
Di Pasquale, P ;
Parrinello, G ;
Cardinale, A ;
Scandurra, A ;
Follone, G ;
Argano, C ;
Tuttolomondo, A ;
Paterna, S .
AMERICAN HEART JOURNAL, 2003, 145 (03) :459-466
[10]   BRAIN NATRIURETIC PEPTIDE IN PLASMA, ATRIA, AND VENTRICLES OF VASOPRESSIN-INFUSED AND PHENYLEPHRINE-INFUSED CONSCIOUS RATS [J].
MAGGA, J ;
MARTTILA, M ;
MANTYMAA, P ;
VUOLTEENAHO, O ;
RUSKOAHO, H .
ENDOCRINOLOGY, 1994, 134 (06) :2505-2515